Table 2.
CGM use over the 26-week study period in participants completing the trial
| CGM use (days/week) | CGM-only group (n = 142) | CGM+BGM group (n = 75) |
|---|---|---|
| Median (interquartile range) | 7.0 (6.5–7.0) | 7.0 (6.7–7.0) |
| Mean ± SD | 6.7 ± 0.5 | 6.8 ± 0.4 |
| 3 to <4 | 1 (<1) | 0 |
| 4 to <5 | 0 | 0 |
| 5 to <6 | 12 (8) | 4 (5) |
| 6 to <7 | 55 (39) | 34 (45) |
| 7 | 74 (52) | 37 (49) |
| <6 | 13 (9) | 4 (5) |
| ≥6 | 129 (91) | 71 (95) |
Data are n (%) unless otherwise indicated.